RNAZ

NASDAQ · Equity

Transcode Therapeutics Inc

US Healthcare Biotechnology

Latest week
29 May 2026
Close
5.140000
Fair value
8473.674830
Expectation
Negative 35.36%
Weekly Close Trend Line Fair Value Activity Lines

Chart Summary

Key Points

Week Ending
29 May 2026
Latest Close
5.14
12-Week Change
-47.47%
Trend Signal
Inactive
Expectation
Negative 35.36%
Signal Weeks
0 of 12
Vs Trend Line
Below
Vs Fair Value
Below
Relative Strength
-55.29
Market Dynamics
-0.54

Over the latest 12 completed weeks ending 2026-05-29, RNAZ fell 47.47%, moving from 9.79 to 5.14. The latest weekly close is below the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -55.29 and has softened across the 12-week window. Market Dynamics is -0.54 on the latest week. Expectation is negative at 35.36%.